Alexander Suvorov1, Marie-Claude Battista, Larissa Takser. 1. Département Obstétrique Gynécologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, Canada. Alexander.Suvorov@USherbrooke.ca
Abstract
BACKGROUND: Polybrominated diphenyl ethers (PBDEs) are a group of environmental contaminants increasing in North America. Few data are available on their growth effects at low doses exposure. OBJECTIVES: Our goal in the present study was to evaluate whether low doses of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47), which is the most abundant PBDE found in human samples, affects growth and insulin-like growth factor 1 (IGF-1). METHODS: Dams were exposed either to the vehicle or low doses of BDE-47 (0.002 and 0.2mg/kgbody weight) every fifth day from gestation day 15 to postnatal day (PND) 20 by intravenous injections. Developmental landmarks, body length and body weight of pups were assessed during the first months of life. A glucose tolerance test was performed on PND 40 and 75. Plasma IGF-1 was analysed in trunk blood on PND 27. RESULTS: Exposure to BDE-47 increased plasma IGF-1 and glucose uptake in male but not in female pups. Developmental landmarks were not influenced by BDE-47 while body weight and body length was increased in both exposed male and female offspring during the first months of development. CONCLUSION: These results demonstrate alteration of growth in rat offspring induced by BDE-47 at levels found in human population. The possible involvement of the growth hormone-IGF axis is discussed.
BACKGROUND:Polybrominated diphenyl ethers (PBDEs) are a group of environmental contaminants increasing in North America. Few data are available on their growth effects at low doses exposure. OBJECTIVES: Our goal in the present study was to evaluate whether low doses of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47), which is the most abundant PBDE found in human samples, affects growth and insulin-like growth factor 1 (IGF-1). METHODS: Dams were exposed either to the vehicle or low doses of BDE-47 (0.002 and 0.2mg/kgbody weight) every fifth day from gestation day 15 to postnatal day (PND) 20 by intravenous injections. Developmental landmarks, body length and body weight of pups were assessed during the first months of life. A glucose tolerance test was performed on PND 40 and 75. Plasma IGF-1 was analysed in trunk blood on PND 27. RESULTS: Exposure to BDE-47 increased plasma IGF-1 and glucose uptake in male but not in female pups. Developmental landmarks were not influenced by BDE-47 while body weight and body length was increased in both exposed male and female offspring during the first months of development. CONCLUSION: These results demonstrate alteration of growth in rat offspring induced by BDE-47 at levels found in human population. The possible involvement of the growth hormone-IGF axis is discussed.
Authors: Hyang-Min Byun; Nora Benachour; Daniel Zalko; Maria Chiara Frisardi; Elena Colicino; Larissa Takser; Andrea A Baccarelli Journal: Toxicology Date: 2014-12-19 Impact factor: 4.221
Authors: Ann M Vuong; Joseph M Braun; Zhiyang Wang; Kimberly Yolton; Changchun Xie; Andreas Sjodin; Glenys M Webster; Bruce P Lanphear; Aimin Chen Journal: Environ Int Date: 2018-12-04 Impact factor: 9.621
Authors: Tram Anh Ta; Claire M Koenig; Mari S Golub; Isaac N Pessah; Lihong Qi; Pavel A Aronov; Robert F Berman Journal: Neurotoxicol Teratol Date: 2011-02-18 Impact factor: 3.763
Authors: Michele La Merrill; Claude Emond; Min Ji Kim; Jean-Philippe Antignac; Bruno Le Bizec; Karine Clément; Linda S Birnbaum; Robert Barouki Journal: Environ Health Perspect Date: 2012-12-05 Impact factor: 9.031